Myositis Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight New York, USA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Myositis Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses...

Orphazyme’s arimoclomol receives US Fast Track designation in sporadic Inclusion Body Myositis Orphazyme A/SCompany announcement                                                                                       No....

Funding provided to shorten lengthy diagnosis time for Myositis EDMONTON, Alberta, June 13, 2017 (GLOBE NEWSWIRE) -- Myositis Canada envisions a world where myositis is quickly and accurately diagnosed and where successful treatments are in place.  Many...

MYOSITIS CANADA Issues Challenge: #GiveMeMuscle TORONTO, ON--(Marketwired - February 25, 2016) - A non-profit Canadian organization dedicated to helping improve the lives of people affected by a rare but debilitating muscle disease is...